2015
DOI: 10.1242/dmm.021246
|View full text |Cite
|
Sign up to set email alerts
|

Loss of the Coffin-Lowry syndrome associated geneRSK2alters ERK activity, synaptic function and axonal transport inDrosophilamotoneurons

Abstract: Plastic changes in synaptic properties are considered as fundamental for adaptive behaviors. Extracellular-signal-regulated kinase (ERK)-mediated signaling has been implicated in regulation of synaptic plasticity. Ribosomal S6 kinase 2 (RSK2) acts as a regulator and downstream effector of ERK. In the brain, RSK2 is predominantly expressed in regions required for learning and memory. Loss-of-function mutations in human RSK2 cause Coffin-Lowry syndrome, which is characterized by severe mental retardation and low… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 60 publications
0
16
0
Order By: Relevance
“…This syndrome is characterized by tall stature, craniofacial defects and mental retardation. Loss of function in human ribosomal S6 kinase 2 (RSK2) causes Coffin-Lowry syndrome, an X-linked disorder characterized by severe mental retardation in males (Beck et al, 2015). RSK2 acts as a regulator of ERK signaling, which may impact cell proliferation and differentiation during brain development.…”
Section: Open-loop Mechanismsmentioning
confidence: 99%
“…This syndrome is characterized by tall stature, craniofacial defects and mental retardation. Loss of function in human ribosomal S6 kinase 2 (RSK2) causes Coffin-Lowry syndrome, an X-linked disorder characterized by severe mental retardation in males (Beck et al, 2015). RSK2 acts as a regulator of ERK signaling, which may impact cell proliferation and differentiation during brain development.…”
Section: Open-loop Mechanismsmentioning
confidence: 99%
“…ders share similar craniofacial features, which makes it challenging to pinpoint the causative gene. Upregulating the ras-MAPK pathway due to loss of function in RPS6KA3 may be related to the similar craniofacial features and mental retardation like in Noonan syndrome 21,22. A previous report also described the experience of misdiagnosis of CLS as Noonan syndrome; the authors identified an RPS6KA3 gene mutation through WES.…”
mentioning
confidence: 94%
“…3 The RPS6KA3 gene encodes a growth factor at the downstream end of the ras-mitogen-activated protein kinase (MAPK) pathway, regulating the serine-threonine kinase.Ribosomal Protein S6 Kinase A3 (RPS6KA3) is directly activated by the extracellular signal kinase (ERK) in response to a range of stimuli, including the growth part of a gene family implicated in cellcycle regulation through the MAPK cascade 20. Upregulating the ras-MAPK pathway due to loss of function in RPS6KA3 may be related to the similar craniofacial features and mental retardation like in Noonan syndrome 21,22. Although CLS is an X-linked dominant disorder, various intellectual deficit in female carriers can be explained by skewed X-chromosome inactivation in the brain which may not be consistent with the status of the X-chromosome in peripheral blood or other tissue 20.…”
mentioning
confidence: 99%
“…Basal synaptic transmission was not affected by RSK inhibition or RSK siRNA. This last result does contrast with the effect of constitutive rsk knockout in mouse (reduction of basal synaptic transmission induced by knockout of rsk2 8 ), and in Drosophila (requirement of a RSK orthologue for normal synaptic morphology and function 23 ). This could be due to the transient (only a few days) and partial knockdown of RSK (Fig.…”
Section: Discussionmentioning
confidence: 85%